Skip to main
CNC
CNC logo

Centene (CNC) Stock Forecast & Price Target

Centene (CNC) Analyst Ratings

Based on 16 analyst ratings
Hold
Strong Buy 6%
Buy 13%
Hold 69%
Sell 6%
Strong Sell 6%

Bulls say

Centene's positive outlook is supported by a notable improvement in its Medicaid Health Benefit Ratio (HBR), which reached 93.4%, marking a year-over-year increase and reflecting successful operational enhancements. The company has improved its Medicare members in 3.5+ Star plans to 60%, indicating better quality performance metrics that could lead to favorable reimbursement rates. Additionally, the anticipated composite rate improvement of approximately 5.5%, along with strong growth in both Medicare and Medicare Part D memberships, underlines Centene's robust position within the government-sponsored healthcare segment.

Bears say

Centene's outlook is negatively impacted by a significant anticipated drop in its portfolio of low-cost Silver positions, declining from 55% in 2025 to 42% by 2026, which may affect revenue stability. Furthermore, the company's guidance for fiscal year 2025 includes a notable pre-tax earnings impact of approximately $2.4 billion due to risk adjustment concerns, indicating weaker financial performance than previously expected. The consistent pressures on Medicaid margin utilization, potential deterioration of marketplace risk scores, and unexpected vulnerabilities in the Medicare Part D business contribute to the overall uncertainty regarding Centene’s financial health.

Centene (CNC) has been analyzed by 16 analysts, with a consensus rating of Hold. 6% of analysts recommend a Strong Buy, 13% recommend Buy, 69% suggest Holding, 6% advise Selling, and 6% predict a Strong Sell.

This aggregate rating is based on analysts' research of Centene and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Centene (CNC) Forecast

Analysts have given Centene (CNC) a Hold based on their latest research and market trends.

According to 16 analysts, Centene (CNC) has a Hold consensus rating as of Dec 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $42.19, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $42.19, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Centene (CNC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.